Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 10, 2017

Quantification of 1,25-dihydroxyvitamin D – value of manufacturers’ product information

  • Michael Vogeser EMAIL logo , Martin Bidlingmaier , Henri Wallaschowski , Johanna Lindner , Jürgen Kratzsch and on behalf of the Division Endocrinological Diagnostics of the German Association of Clinical Chemistry and Laboratory Medicine (DGKL)
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Holick FM. Vitamin D deficiency. N Engl J Med 2007;357:266–81.10.1056/NEJMra070553Search in Google Scholar

2. Risteli J, Winter WE, Kleerekoper M, Risteli L. Bone and mineral metabolism. In: Burtis CA, Edward R, Ashwood MD, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St. Louis, USA: Elsevier ISBN: 9781416061649.Search in Google Scholar

3. Asao K, McHugh JB, Miller DC, Esfandiari NH. Hypercalcemia in upper urinary tract urothelial carcinoma: a case report and literature review. Case Rep Endocrinol 2013;2013:470890.10.1155/2013/470890Search in Google Scholar

4. Shah R, Licata A, Oyesiku NM, Ioachimescu AG. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature. Pituitary 2012;15 (Suppl 1):S17–22.10.1007/s11102-010-0286-8Search in Google Scholar

5. Molin A, Baudoin R, Kaufmann M, Souberbielle JC, Ryckewaert A, Vantyghem MC, et al. CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J Clin Endocrinol Metab 2015;100:E1343–52.10.1210/jc.2014-4387Search in Google Scholar

6. Ward LM, Rauch F, White KE, Filler G, Matzingketter MA, Letts M, et al. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone 2004;34:905–11.10.1016/j.bone.2003.12.025Search in Google Scholar

7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.10.1210/jc.2011-0385Search in Google Scholar

8. Eknoyan G, Levin A, Levin NW. Kidney disease outcomes quality initiatives (KDOQI). Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(Suppl 3): 1–201.10.1016/S0272-6386(03)00905-3Search in Google Scholar

9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;113:S1–130.Search in Google Scholar

10. Zimmerman D, House AA, Kim SJ, Booth RA, Zhang T, Ramsay T, et al. The risk of acute rejection following kidney transplant by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D status: a prospective cohort study. Can J Kidney Health Dis 2017;4:1–10.10.1177/2054358117699822Search in Google Scholar

11. Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Min Res 2007;22:1668–71.10.1359/jbmr.070716Search in Google Scholar

12. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95–6.10.1016/S0140-6736(11)61816-3Search in Google Scholar

13. Plebani M. Towards a new paradigm in laboratory medicine: the five rights. Clin Chem Lab Med 2016;54:1881–91.10.1515/cclm-2016-0848Search in Google Scholar PubMed

14. Epner PL, Gans JE, Graber ML. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Qal Saf 2013;22:ii6–10.10.1136/bmjqs-2012-001621Search in Google Scholar PubMed PubMed Central

Received: 2017-05-04
Accepted: 2017-07-03
Published Online: 2017-08-10
Published in Print: 2018-01-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2017-0385/html
Scroll to top button